Homebiotech

biotech

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026

biotech

New approach to treating chronic wounds

Jim Cornall - October 7, 2026

biotech

Hidden amplification switch has implications for cancer metastasis

Jim Cornall - October 7, 2026

biotech

Recreating key features of the antibody factory in a dish

Jim Cornall - October 7, 2026

biotech

Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin

Jim Cornall - December 19, 2025

biotech

Sobi boosts gout battle with Arthrosi Therapeutics acquisition

Jim Cornall - December 18, 2025

biotech

Immune ‘switch’ is potential target to curb chronic inflammation in cirrhosis

Jim Cornall - December 18, 2025

biotech

InnoCare to move to phase 3 after achieving SLE endpoints

Jim Cornall - December 18, 2025

biotech

First precision therapy prostate cancer drug approved

Jim Cornall - December 17, 2025

biotech

FDA approves generalised myasthenia gravis drug

Jim Cornall - December 17, 2025

biotech

Breast cancer vaccine endpoints met with 74% immune response

Jim Cornall - December 17, 2025

biotech

Lilly to build $6bn Alabama facility

Jim Cornall - December 16, 2025

1...585960...104 Page 59 of 104

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026 0

Bacterial toxins can create pores in epithelial cell membranes, threatening cell survival and weakening the body’s protective barriers. Yet when these barriers are breached,...

New approach to treating chronic wounds

biotech Jim Cornall - October 7, 2026 0

Hidden amplification switch has implications for cancer metastasis

biotech Jim Cornall - October 7, 2026 0

Recreating key features of the antibody factory in a dish

biotech Jim Cornall - October 7, 2026 0

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

biotech Jim Cornall - October 6, 2026 0